Biology Reference
In-Depth Information
McHeyzer-Williams MG, Davis MM. 1995. Antigen-speci®c development of primary and memory
T cells in vivo. Science 268: 106±111.
Mongkolsapaya J, Jaye A, Callan MFC, Magnusen AF, McMichael AJ, Whittle HC. 1999.
Antigen-speci®c expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol
73: 67±71.
Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. 1993. Virus persistence in acutely infected
immunocompetent mice by exhaustion of antiviral cytotoxic e¨ector T cells. Nature 362: 758±
761.
Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. 1997. Cytotoxic T cell responses,
viral load, and disease progression in early human immunode®ciency virus type 1 infection. New
Engl J Med 337: 1267±1274.
Ogg GS, Jin X, Bonhoe¨er S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones
SL, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF. 1999. Decay kinetics of
human immunode®ciency virus-speci®c e¨ector cytotoxic T lymphocytes after combination
antiretroviral therapy. J Virol 73: 797±800.
Oxenius A, Zinkernagel RM, Hengartner H. 1998. Comparison of activation versus induction of
unresponsiveness of virus-speci®c CD4
and CD8
T cells upon acute versus persistent viral
infection. Immunity 9: 449±457.
Pakker NG, Kroon EDMB, Roos MTL, Otto SA, Hall D, Wit FWNM, Hamann D, van der Ende
ME, Claessen FAP, Kau¨mann RH, Koopmans PP, Kroon FP, ten Napel CHH, Sprenger HG,
Weigel HM, Montaner JSG, Lange JMA, Reiss P, Schellekens PTA, Miedema F. 1998a. Im-
mune restoration does not invariably occur following long-term HIV-1 suppression during
antiretroviral therapy. AIDS 13: 203±212.
Pakker NG, Notermans DW, de Boer RJ, Roos MTL, de Wolf F, Hill A, Leonard JM, Danner SA,
Miedema F, Schellekens PTA. 1998b. Biphasic kinetics of peripheral blood T cells after triple
combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat
Med 4: 208±214.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ,
Holmberg SD. 1998. Declining morbidity and mortality among patients with advanced human
immunode®ciency virus infection. HIV outpatient study investigators. N Engl J Med 338: 853±
860.
Paliard X, West SG, La¨erty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. 1991. Evi-
dence for the e¨ects of a superantigen in rheumatoid arthritis. Science 253: 325±329.
Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. 1993. The sizes of the
CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the
recombined germ-line segments. Proc Natl Acad Sci USA 90: 4319±4323.
Pannetier C, Even J, Kourilsky P. 1995. T-cell repertoire diversity and clonal expansions in normal
and clinical samples. Immunol Today 16: 176±181.
Pantaleo G. 1997. How immune-based intervention can change HIV therapy. Nat Med 3: 483±486.
Pantaleo G, Fauci AS. 1995. New concepts in the immunopathogenesis of HIV infection. Annu Rev
Immunol 13: 487±512.
Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, Fauci AS. 1991. Lym-
phoid organs function as major reservoirs for human immunode®ciency virus. Proc Natl Acad
Sci USA 88: 9838±9842.
Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP,
Fauci AS. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically
latent stage of disease. Nature 362: 355±358.
Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS,
Shaw GM, Sekaly RP, Fauci AS. 1994. Major expansion of CD8
T lymphocytes with a pre-
dominant Vb usage during the primary immune response to HIV. Nature 370: 463±467.
